| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.9M | — | — |
| Cost of Revenue | $587K | — | — |
| R&D Expense | $13.4M | — | -44.0% |
| SG&A Expense | $13.4M | — | +20.2% |
| Operating Income | -$17.4M | — | +50.2% |
| Pre-tax Income | $51.3M | — | +236.6% |
| Income Tax | $57K | — | — |
| Net Income | $56.1M | — | +267.5% |
| EPS (Basic) | $0.78 | — | +234.5% |
| EPS (Diluted) | $0.62 | — | +206.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.9M | -80.3% | -55.3% |
| Short-term Investments | $133.4M | -17.7% | +177.1% |
| Accounts Receivable | $6.7M | — | -4.7% |
| Inventory | $183K | — | — |
| Current Assets | $180.4M | -16.4% | +87.5% |
| Total Assets | $286.2M | -12.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$14.5M | — | +59.5% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $28.7M | — | -25.4% |
| Financing Cash Flow | -$22.0M | — | -1095.3% |
| Free Cash Flow | -$14.5M | — | +59.6% |
| +21.7% |
| Current Liabilities | $59.4M | -23.9% | -28.6% |
| Stockholders' Equity | -$63.3M | +47.8% | +70.3% |